Over the past two decades, the Polish CRO industry has transformed dramatically. What began with simple monitoring tasks has evolved into comprehensive offerings, covering full-process management, data analysis, and early-phase trials.
Today, the value of clinical trials in Poland stands at approximately €1.5 billion, contributing to an overall European market of around €12 billion, which is growing steadily at a rate of 5–6% year-on-year.
Thanks to private investments and robust scientific infrastructure, Poland and the CEE region have established a compelling position in global clinical research. Their emergence is a story of rapid evolution—from a supportive environment into a true innovation hub.
Marcel Zatoński (Puls Biznesu) helped highlight this transformation in a recent article. Don’t miss the full story: read the piece here (in Polish).
Modern nuclear medicine is a high-tech discipline that requires advanced facilities, infrastructure, qualified staff, and know-how. The reliable supply of radionuclides,…
How Axcellant stabilized isotope supply, synchronized global imaging operations, and prevented a multi-month program delay. At a Glance Study type:…
At Axcellant, we work where medtech becomes real, not in headlines but in clinics, documentation, and decisions that must stand…
Copyright @ 2026 Axcellant